Clinical Trial Details

A Randomized Phase II Study Comparing Sequential High dose Testosterone and Enzalutamide to Enzalutamide alone in Asymptomatic Men with Castration Resistant Metastatic Prostate Cancer

Categories (click each to see list of all clinical trials associated with that category): GU (ONC)

Current Status: Open

Phase: II (Cancer Control)

Principal Investigator: Teply, Benjamin

Contact Information:
Amanda Redmond
aredmond@unmc.edu

Eligibility: https://clinicaltrials.gov/ct2/show/study/NCT04363164?term=04363164&draw=2&rank=1#eligibility

Summary
The primary objective of the study is to determine if treatment with sequential high dose testosterone and Enza (STE) or variable sequential high dose T/Enza (VSTE) will improve clinical/radiographic progression free survival (crPFS) compared to Enza in asymptomatic men with evidence of progressive metastatic CRPC post-treatment with abiraterone.